Cardiac risk stratification in patients undergoing endoluminal graft repair of abdominal aortic aneurysm: A single-institution experience with 365 patients

Objective: Patients undergoing abdominal aortic aneurysm repair have a high incidence of coexisting cardiac disease. The traditional cardiac risk stratification for open abdominal aortic aneurysm surgery may not apply to patients undergoing endoluminal graft exclusion. The purpose of this study was to examine predictive risk factors for perioperative cardiac events. Methods. As part of multiple prospective endograft trials approved by the US Food and Drug Administration, data for 365 patients who underwent endoluminal graft repair from 1996 to 2001 were collected. Variables included for analysis were age and sex; history of smoking; presence of hypertension, diabetes mellitus, or renal insufficiency; Eagle clinical cardiac risk factors; American Society of Anesthesiologists index; type of anesthesia administered; estimated blood loss; preoperative hemoglobin level; preoperative use of beta-blocker therapy; duration of surgery; need for iliac artery conduit; and concomitant other vascular procedures. Univariate and multivariate logistic regression analysis were used to determine which variables were predictive of an adverse perioperative cardiac event, eg, Q wave and non-Q wave myocardial infarction (MI), congestive heart failure (CHF), severe arrhythmia, and unstable angina. Results. The study cohort included 322 men and 43 women (mean age, 74.2 years). Fifty-two (14.2%) postoperative cardiac events occurred: severe dysrhythmia in 15 patients (4.1%), MI in 14 patients (3.8%), non-Q wave MI in 8 patients, (2.2%), CHF in 8 patients (2.2%), and unstable angina in 7 patients (1.9%). Univariate analygis demonstrated that age 70 years or older (P = .034), history of MI (P = .018), angina (P = .004), history of CHF (P < .001), two or more Eagle risk factors (P < .001), and lack of use of preoperative P-blocker therapy (P = .005) were predictors of perioperative cardiac events. Multivariate analysis identified only age 70 years or older (P = .026), history of MI (P =.024) or CHF (P = .001), and lack of use of preoperative beta-blocker therapy (P =.007) as independent risk factors for an adverse cardiac event. Conclusions. Age 70 years or older, history of MI or CHF, and lack of use of preoperative P-blocker therapy are independent risk factors for perioperative cardiac events in patients undergoing endoluminal graft repair.